ADAGENE ANNOUNCES PARTICIPATION AT LEERINK’S GLOBAL HEALTHCARE CONFERENCE 2025

KUALA LUMPUR, March 7 (Bernama) -- Adagene Inc (Adagene) has announced its Chairman, Chief Executive Officer and President of R&D, Dr Peter Luo, will participate in one-on-one investor meetings and provide a corporate update at Leerink’s Global Healthcare Conference 2025.

The conference will take place from March 10 to 12 in Miami, Florida. Dr Luo’s presentation is scheduled for March 12 at W South Beach, and a webcast of the presentation will be accessible in the investors section of the company’s website for 30 days, according to Adagene in a statement.

A platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies, Adagene combines computational biology and artificial intelligence to design novel antibodies that address globally unmet patient needs.

The company has forged strategic collaborations with reputable global partners that leverage its SAFEbody precision masking technology in multiple approaches at the vanguard of science.

-- BERNAMA